ArticleJournal of cancer research and clinical oncology2023

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor.

Ying Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.